Literature DB >> 10923835

Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells.

B S Min1, J J Gao, N Nakamura, M Hattori.   

Abstract

Six new highly oxygenated lanostane-type triterpenes, called ganoderic acid gamma (1), ganoderic acid delta (2), ganoderic acid epsilon (3), ganoderic acid zeta (4), ganoderic acid eta (5) and ganoderic acid theta (6), were isolated from the spores of Ganoderma lucidum, together with known ganolucidic acid D (7) and ganoderic acid C2 (8). Their structures of the new triterpenes were determined as (23S)-7beta,15alpha,23-trihydroxy-3,11-dioxolanosta-8, 24(E)-diene-26-oic acid (1), (23S)-7alpha,15alpha23-trihydroxy-3,11-dioxolanosta-8, 24(E)-diene-26-oic acid (2), (23S)-3beta3,7beta, 23-trihydroxy-11,15-dioxolanosta-8,24(E)-diene-26-oic acid (3), (23S)-3beta,23-dihydroxy-7,11,15-trioxolanosta-8, 24(E)-diene-26-oic acid (4), (23S)-3beta,7beta,12beta,23-tetrahydroxy-11,15-dioxolanos ta-8,24(E)-diene-26-oic acid (5) and (23S)-3beta,12beta23-trihydroxy-7,11,15-trioxolanosta-8,24(E )-diene-26-oic acid (6), respectively, by chemical and spectroscopic means, which included the determination of a chiral center in the side chain by a modification of Mosher's method. The cytotoxicity of the compounds isolated from the Ganoderma spores was carried out in vitro against Meth-A and LLC tumor cell lines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10923835     DOI: 10.1248/cpb.48.1026

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  22 in total

1.  Ganoderic acid C1 isolated from the anti-asthma formula, ASHMI™ suppresses TNF-α production by mouse macrophages and peripheral blood mononuclear cells from asthma patients.

Authors:  Changda Liu; Nan Yang; Ying Song; Lixin Wang; Jiachen Zi; Shuwei Zhang; David Dunkin; Paula Busse; David Weir; Jody Tversky; Rachel L Miller; Joseph Goldfarb; Jixun Zhan; Xiu-Min Li
Journal:  Int Immunopharmacol       Date:  2015-05-21       Impact factor: 4.932

2.  Analysis of triterpenoids in ganoderma lucidum using liquid chromatography coupled with electrospray ionization mass spectrometry.

Authors:  Min Yang; Xiaoming Wang; Shuhong Guan; Jiameng Xia; Jianghao Sun; Hui Guo; De-An Guo
Journal:  J Am Soc Mass Spectrom       Date:  2007-03-26       Impact factor: 3.109

Review 3.  Misconstrued versatility of Ganoderma lucidum: a key player in multi-targeted cellular signaling.

Authors:  Balraj Singh Gill; Prateek Sharma; Raj Kumar; Sanjeev Kumar
Journal:  Tumour Biol       Date:  2015-12-30

Review 4.  The in vitro and in vivo experimental evidences disclose the chemopreventive effects of Ganoderma lucidum on cancer invasion and metastasis.

Authors:  Chia-Jui Weng; Gow-Chin Yen
Journal:  Clin Exp Metastasis       Date:  2010-05-12       Impact factor: 5.150

5.  Metabolism and pharmacokinetics in rats of ganoderiol F, a highly cytotoxic and antitumor triterpene from Ganoderma lucidum.

Authors:  Qun Zhang; Feng Zuo; Norio Nakamura; Chao-Mei Ma; Masao Hattori
Journal:  J Nat Med       Date:  2009-05-01       Impact factor: 2.343

6.  Induction of apoptosis in the SW620 colon carcinoma cell line by triterpene-enriched extracts from Ganoderma lucidum through activation of caspase-3.

Authors:  Zhe Ji; Qingjiu Tang; Ruixia Hao; Jinsong Zhang; Yingjie Pan
Journal:  Oncol Lett       Date:  2011-03-21       Impact factor: 2.967

Review 7.  Mushrooms: an emerging resource for therapeutic terpenoids.

Authors:  Adhiraj Dasgupta; Krishnendu Acharya
Journal:  3 Biotech       Date:  2019-09-24       Impact factor: 2.406

Review 8.  Lupeol, a novel anti-inflammatory and anti-cancer dietary triterpene.

Authors:  Mohammad Saleem
Journal:  Cancer Lett       Date:  2009-05-22       Impact factor: 8.679

Review 9.  The effects of beta-glucan on human immune and cancer cells.

Authors:  Godfrey Chi-Fung Chan; Wing Keung Chan; Daniel Man-Yuen Sze
Journal:  J Hematol Oncol       Date:  2009-06-10       Impact factor: 17.388

Review 10.  Ganoderma lucidum (Reishi mushroom) for cancer treatment.

Authors:  Xingzhong Jin; Julieta Ruiz Beguerie; Daniel Man-Yeun Sze; Godfrey C F Chan
Journal:  Cochrane Database Syst Rev       Date:  2016-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.